RENEO PHARMACEUTICALS INC (RPHM) Stock Analyst Earnings Estimates
NASDAQ:RPHM - Nasdaq - US75974E1038 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 76.27% | N/A 57.46% | N/A 57.41% | N/A 37.56% | ||||||
| EBITDA YoY % growth | -15.44M | -19.51M -26.36% | -39.77M -103.84% | -53.76M -35.18% | -82.883M -54.17% | N/A 42.39% | N/A 38.28% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.47M | -19.55M -26.37% | -39.82M -103.68% | -53.85M -35.23% | -83.053M -54.23% | N/A 68.38% | N/A 5.40% | N/A 6.08% | N/A 328.00% | N/A 203.45% | N/A 106.34% | N/A 53.24% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -4.86 | -2.12 56.38% | -2.53 -19.34% | N/A 73.79% | N/A 14.62% | N/A 359.46% | N/A 190.97% | N/A 36.52% | N/A 26.22% | N/A 29.78% |
All data in USD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 87.47% | -0.07 89.94% | -0.57 -128.48% | -0.51 -218.75% | -0.32 -342.86% | -0.19 -171.43% |
| Revenue Q2Q % growth | 8.127M | 16.281M | ||||
| EBITDA Q2Q % growth | -8.894M 57.16% | -5.743M 76.88% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.315M 84.13% | -3.315M 86.74% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.16 75.38% | -0.10 | -0.06 | -56.86% |
| Q1 2024 Q2Q % growth | -0.25 58.33% | -0.45 | 0.20 | 43.87% |
| Q4 2023 Q2Q % growth | -0.71 -26.79% | -0.59 | -0.12 | -20.47% |
| Q3 2023 Q2Q % growth | -0.57 -7.55% | -0.58 | 0.01 | 2.21% |
| Q2 2023 Q2Q % growth | -0.65 -30.00% | -0.53 | -0.12 | -23.34% |
| Q1 2023 Q2Q % growth | -0.60 -13.21% | -0.62 | 0.02 | 2.61% |
| Q4 2022 Q2Q % growth | -0.56 -30.23% | -0.61 | 0.05 | 8.62% |
| Q3 2022 Q2Q % growth | -0.53 -1.92% | -0.58 | 0.05 | 9.11% |
| Q2 2022 Q2Q % growth | -0.50 -16.28% | -0.59 | 0.09 | 15.77% |
| Q1 2022 Q2Q % growth | -0.53 84.77% | -0.55 | 0.02 | 4.37% |
| Q4 2021 Q2Q % growth | -0.43 | -0.58 | 0.15 | 26.04% |
| Q3 2021 Q2Q % growth | -0.52 | -0.48 | -0.04 | -7.71% |
| Q2 2021 Q2Q % growth | -0.43 | -0.38 | -0.05 | -11.92% |
| Q1 2021 Q2Q % growth | -3.48 | -0.39 | -3.09 | -797.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |